Abstract
Transient Receptor Potential Vanilloid Type 1 is a prominent “pain” receptor expressed in sensory afferent neurons. TRPV1 on peripheral nerve terminals detects a variety of noxious stimuli generated at sites of injury and inflammation, and in turn, drives the excitation and sensitization of C-fiber neurons. Significantly, TRPV1 is also located on the central terminals of sensory neurons projecting to the spinal cord and brainstem. These TRPV1 channels appear to stimulate the secretion of glutamate. Further, TRPV1 is expressed diffusely in the brain and there is emerging evidence for TRPV1 modulating transmission at various brain synapses. Here we discuss our current understanding of the potential roles for TRPV1 in synaptic transmission.
Keywords: Brain, CNS, pain, presynaptic, spinal cord, TRPV1, Synaptic Transmission, sensory afferent neurons, capsaicin, synaptophysin, noxious stimuli, amygdala, periaqueductal gray, TRPV1 mRNA, tetrodotoxin, vanilloids, eicosanoids, (PKC) activation, PIP2, mEPSCs, TRPV1 channels, PKC stimulation, hippocampal neurons, presynaptic dopamine receptors, EPSC amplitude, endovanilloids, dopaminergic neurons, GABAergic transmission, nociceptive responses, neurohypophysis, capsazepine, PLC signaling
Current Pharmaceutical Biotechnology
Title: TRPV1 and Synaptic Transmission
Volume: 12 Issue: 1
Author(s): Jose A. Matta and Gerard P. Ahern
Affiliation:
Keywords: Brain, CNS, pain, presynaptic, spinal cord, TRPV1, Synaptic Transmission, sensory afferent neurons, capsaicin, synaptophysin, noxious stimuli, amygdala, periaqueductal gray, TRPV1 mRNA, tetrodotoxin, vanilloids, eicosanoids, (PKC) activation, PIP2, mEPSCs, TRPV1 channels, PKC stimulation, hippocampal neurons, presynaptic dopamine receptors, EPSC amplitude, endovanilloids, dopaminergic neurons, GABAergic transmission, nociceptive responses, neurohypophysis, capsazepine, PLC signaling
Abstract: Transient Receptor Potential Vanilloid Type 1 is a prominent “pain” receptor expressed in sensory afferent neurons. TRPV1 on peripheral nerve terminals detects a variety of noxious stimuli generated at sites of injury and inflammation, and in turn, drives the excitation and sensitization of C-fiber neurons. Significantly, TRPV1 is also located on the central terminals of sensory neurons projecting to the spinal cord and brainstem. These TRPV1 channels appear to stimulate the secretion of glutamate. Further, TRPV1 is expressed diffusely in the brain and there is emerging evidence for TRPV1 modulating transmission at various brain synapses. Here we discuss our current understanding of the potential roles for TRPV1 in synaptic transmission.
Export Options
About this article
Cite this article as:
A. Matta Jose and P. Ahern Gerard, TRPV1 and Synaptic Transmission, Current Pharmaceutical Biotechnology 2011; 12 (1) . https://dx.doi.org/10.2174/138920111793937925
DOI https://dx.doi.org/10.2174/138920111793937925 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
INTRODUCTORY CONSIDERATIONS Athanasios Koukopoulos: The Man, the Psychiatrist, the Original Thinker
Current Neuropharmacology Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimers Disease
Current Pharmaceutical Design The Use of Psychoactive Substances and Illegal Drugs in the Albanian Society
Current Drug Research Reviews Uncovering γ-Secretase
Current Alzheimer Research Editorial (Thematic Issue: New Approaches to the Treatment of Alzheimer's Disease)
Current Topics in Medicinal Chemistry Acknowledgements to Reviewers
Recent Patents on CNS Drug Discovery (Discontinued) Kallikrein-Kinin System Mediated Inflammation in Alzheimers Disease In Vivo
Current Alzheimer Research A Comparative Summary on Antioxidant-like Actions of Timolol with Other Antioxidants in Diabetic Cardiomyopathy
Current Drug Delivery Supercritical Fluid Particle Design of DPI Formulations (Review)
Current Pharmaceutical Design Alkaloids and Flavonoids as α1-Adrenergic Receptor Antagonists
Current Medicinal Chemistry A Role for Calcineurin in Alzheimers Disease
Current Neuropharmacology Effect of Ionic Strength on the Aggregation Propensity of Aβ<sub>1-42</sub> Peptide: An In-silico Study
Current Chemical Biology Nanocarriers for Systemic and Mucosal Vaccine Delivery
Recent Patents on Drug Delivery & Formulation Oxidative Imbalance and Anxiety Disorders
Current Neuropharmacology Gyroxin and Its Biological Activity: Effects on CNS Basement Membranes and Endothelium and Protease-Activated Receptors
Current Medicinal Chemistry Activity-dependent Synaptic Plasticity and Metaplasticity in Spinal Motor Networks
Current Pharmaceutical Design The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer’s Disease
Current Alzheimer Research Sudden Infant Death Syndrome: Implications of Altered Physiological Control During Sleep
Current Pediatric Reviews Abeta DNA Vaccination for Alzheimers Disease: Focus on Disease Prevention
CNS & Neurological Disorders - Drug Targets Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness
Current Pharmaceutical Design